The Washington monthly journalism award: October 2001.BARRY YEOMAN "The Quiet War on Abortion" Mother Jones, October 2001 After years of noisy protests and civil disobedience civil disobedience, refusal to obey a law or follow a policy believed to be unjust. Practitioners of civil disobediance basing their actions on moral right and usually employ the nonviolent technique of passive resistance in order to bring wider attention to the by anti-abortion activists, the abortion wars finally seemed to subside after the assassination Assassination See also Murder. assassins Fanatical Moslem sect that smoked hashish and murdered Crusaders (11th—12th centuries). [Islamic Hist.: Brewer Note-Book, 52] Brutus conspirator and assassin of Julius Caesar. [Br. of several doctors. But Barry Yeoman yeoman (yō`mən), class in English society. The term has always been ill-defined, but generally it means a freeholder of a lower status than gentleman who cultivates his own land. explains that far from abandoning the cause, anti-abortion activists have simply gotten cagier. Keeping a low profile, activists are now chipping away at abortion rights discreetly with low-profile legislation and lawsuits that stop short of trying to outlaw the procedure and instead barrage providers with suits about building code violations and other issues that make it next to impossible for them to do business. JON COHEN AND ELIOT MARSHALL "Vaccines for Biodefense: A System in Distress" Science, October 19, 2001 According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Cohen cohen or kohen (Hebrew: “priest”) Jewish priest descended from Zadok (a descendant of Aaron), priest at the First Temple of Jerusalem. The biblical priesthood was hereditary and male. and Marshall, months before the September 11 terrorist attacks, the U.S. Defense Department informed Congress that its system for developing vaccines to protect troops from bioweapons was a disastrous failure. Cohen and Marshall explain how, despite the military's need for exotic new shots, vaccine development has lagged thanks to a lack of commercial interest and management snafus. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion